A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants

Mayo Clinic Proceedings

Volumn 84, Issue 3, 2009, Pages 221-228

  Adolphe, Allen ^a   Cook, Linda S ^a   Huang, Xun ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; SCORING SYSTEM;

EID: 62749206241     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/84.3.221     Document Type: Article

References (49)

1. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-1847.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553.
3. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366(9491):1059-1062.
4. Balkau B, Charles MA; European Group for the Study of Insulin Resistance (EGIR). Comment on the provisional report from the WHO consultation [letter]. Diabet Med. 1999;16(5):442-443.
5. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: Executive summary. Cardiol Rev. 2005;13(6):322-327.
6. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96(5):1432-1437.
7. Staub D, Meyerhans A, Bundi B, Schmid HP, Frauchiger B. Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Circulation. 2006 Mar;37(3):800-805. Epub 2006 Jan 26.
8. 2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin infarction study-II (NOBIS-II). Clin Res Cardiol. 2007 Sep;96(9):604-612. Epub 2007 Jun 27.
9. Virani SS, Polsani VR, Nambi V. Novel markers of inflammation in atherosclerosis. Current Atheroscler Rep. 2008;10(2):164-170.
10. Tsimikas S. In vivo markers of oxidative stress and therapeutic interventions. Am J Cardiol. 2008;101(10A):34D-42D.
11. Crandal MA, Corson MA. Use of biomarkers to develop treatment strategies for atherosclerosis. Curr Treat Options Cardiovasc Med. 2008;10(4):304-315.
12. Armutcu F, Ataymen M, Atmaca H, Gurel A. Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Clin Chem Lab Med. 2008;46(6):785-790.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
14. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9(3):237-252.
15. Blaha MJ, Bansal S, Rouf R, Golden SH, Blumenthal RS, Defilippis AP. A practical "ABCDE" approach to the metabolic syndrome. Mayo Clin Proc. 2008;83(8):932-941.
16. Kahn R. Metabolic syndrome: is it a syndrome? does it matter? Circulation. 2007;115(13):1806-1810.
17. Beaser RS, Levy P. Metabolic syndrome: a work in progress, but a useful construct. Circulation. 2007;115(13):1812-1818.
18. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
19. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004 Sep 7;110(10):1245-1250. Epub Aug 23.
20. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004 Sep 7;110(10):1251-1257. Epub 2004 Aug 23.
21. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005 Nov 15;112(20):3066-3072. Epub 2005 Nov 7.
22. de Simone G, Devereux RB, Chinali M, et al; Strong Heart Study Investigators. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care. 2007 Jul;30(7):1851-1856. Epub 2007 Apr 17.
23. Fadini GP, Coracina A, Inchiostro S, Tiengo A, Avogaro A, de Kreutzenberg SV. A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. Eur J Cardiovasc Prev Rehabil. 2008;15(2):190-196.
24. Craven TE, Ryu JE, Espeland MA, et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study. Circulation. 1990;82(4):1230-1242.
25. Crouse JR III. B-mode ultrasound in clinical trials: answers and questions [editorial]. Circulation. 1993;88(1):319-321.
26. Cuspidi C, Meani S, Valerio C, et al. Age and target organ damage in essential hypertension: role of the metabolic syndrome. Am J Hypertens. 2007;20(3):296-303.
27. Burke GL, Evans GW, Riley WA, et al; ARIC Study Group. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 1995;26(3):386-391.
28. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke. 1999;30(4):841-850.
29. O'Leary DH, Polak JF, Kronmal RA, et al; Cardiovascular Health Study Collaborative Research Group. Thickening of the carotid wall: a marker for atherosclerosis in the elderly? Stroke. 1996;27(2):224-231.
30. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (the Bogalusa Heart Study). Am J Cardiol. 2002;90:953-958.
31. Newman WP III, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med. 1986;314:138-144.
32. Scuteri A, Najjar SS, Muller DC, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004;43(8):1388-1395.
33. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP; PDAY Research Group. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscler Thromb Vasc Biol. 1997;17(1):95-106.
34. Crouse JR III. Imaging atherosclerosis: state of the art. J Lipid Res. 2006 Aug;47(8):1677-1699. Epub 2006 May 16.
35. de Groot E, Jukema JW, Montauban van Swijndregt AD, et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol. 1998;31(7):1561-1567.
36. Crouse JR III, Raichlen JS, Riley WA, et al; METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007 Mar 28;297(12):1344-1353. Epub 2007 Mar 25.
37. Kastelein JJ, Akdim F, Stroes ES, et al; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia [published correction appears in N Engl J Med. 2008;358(18):1977]. N Engl J Med. 2008 Apr 3;358(14):1431-1443. Epub 2008 Mar 30.
38. Pasternak RC, Grundy SM, Levy D, Thompson PD. Task Force 3. Spectrum of risk factors for coronary heart disease. J Am Coll Cardiol. 1996;27(5):978-990.
39. Andreadis EA, Tsourous GI, Tzavara CK, et al. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population. Am J Hypertens. 2007;20(5):558-564.
40. Guize L, Thomas F, Pannier B, Bean K, Jego B, Benetos A. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care. 2007 Sep;30(9):2381-2387. Epub Jun 11.
41. Ballantyne CM, Hoogeveen RC, McNeill AM, et al. Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes (Lond). 2008;32(suppl 2):S21-S24.
42. Fortson J, Howe L, Harmon C, Sherrill WW. Targeting cardiovascular risk: early identification of insulin resistance. J Am Acad Nurse Pract. 2008;20(6):319-325.
43. DECODE Study Group; Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia. 2006 Dec;49(12):2837-2846. Epub 2006 Oct 5.
44. Hoang KC, Ghandehari H, Lopez VA, Barboza MG, Wong ND. Global coronary heart disease risk assessment of individuals with the metabolic syndrome in the U.S. Diabetes Care. 2008 Jul;31(7):1405-1409. Epub 2008 Mar 28.
45. Gustiene O, Slapikas R, Marcinkeviciene J, et al. Relationship between the metabolic syndrome, endothelial function and intima-media thickness in asymptomatic middle-aged individuals [in Lithuanian]. Medicina (Kaunas). 2005;41(10):825-836.
46. Baldassarre D, Amato M, Bondioli A, Sirtori CR, Tremoli E. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke. 2000;31(10):2426-2430.
47. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006 Jan;37(1):87-92. Epub 2005 Dec 8.
48. Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 2002;106(16):2055-2060.
49. OKeefe JH, Bybee KA, Lavie CJ. Intensive lipid intervention in the post-ENHANCE era [editorial]. Mayo Clin Proc. 2008;83(8):867-869.